This finding supports the notion that anti-IFN-γ autoantibodies, which reduce IL-12/IL-23 levels, may also be produced to modulate ongoing IFN-γ production by thyroid follicular cells in patients with autoimmune thyroiditis (26). This evidence concerns the gene IFNG and autoimmune thyroid disease.